Abstract Body

We have identified a novel subset of NK cells, called ‘g-NK cells’, which display adaptive immune features, including clonal-like expansion and long-term persistence. The presence of g-NK cells is associated with previous infection by cytomegalovirus and have enhanced response to broad range of viral-infected cells in the presence of virus-specific antibodies. We hypothesize that g-NK cells contribute to low CD4 counts in HIV patients and CD4 recovery during ART.

In a cohort of 18 MSM chronically infected HIV patients naïve to treatment before and 12 months after starting a PI-based cART, the presence of g-NK cells, as well as their frequencies and phenotypic characteristics, were measured by flow cytometry after intracellular staining of FcR-gamma signaling protein following cell surface marker staining. 17 HIV-negative control underwent identical procedures. Plasma biomarkers of inflammation were measured by ELISA and cytokine production by g-NK cells and conventional NK cells after stimulation with HIV-infected cells in the presence or absence of HIV-seropositive plasma.

We observed that (1) HIV patients possessed higher frequencies of g-NK cells compared to HIV-negative control groups [39.9% and 10.33%, p=0.0320], (2) HIV patients with readily detectable g-NK cells show a trend toward lower CD4+ T cell count before [p<0.08] and 1 yr after cART [p<0.01]. g-NK cells did not change levels before and after the treatment, and (3) compared to conventional NK cells, g-NK cells produced greater amount of IFN- and TNF- in response to HIV-infected cells in the presence of HIV-seropositive plasma.

g-NK cells are more frequent in HIV-infected patients compared to controls and may contribute to low CD4 counts in HIV patients and poor recovery during ART. g-NK cells may be a useful biomarker for predicting how the CD4+ T cell population may recover during HIV treatment.